Importantly, the patient with ATRT and later MPNST had no evidence of germline alterations in SMARCB1, SMARCA4, NF1 or TP53. One patient succumbed to his secondary malignancy. The gene discussed is SMARCB1; the disease is atypical teratoid rhabdoid tumor.